Molecular analysis of staphylococcal superantigens

Methods in Molecular Biology

Volumn 1085, Issue , 2014, Pages 169-185

  Salgado Pabón, Wilmara ^a   Case Cook, Laura C ^b   Schlievert, Patrick M ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Extreme pyrexia; Infective endocarditis; Pneumonia; Purpura fulminans; Staphylococcus aureus; Superantigens; Toxic shock syndrome

Indexed keywords

ANTISERUM; EXOTOXIN; STAPHYLOCOCCAL SUPERANTIGEN; STAPHYLOCOCCUS ENTEROTOXIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; IMMUNOBLOTTING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; STAPHYLOCOCCUS AUREUS;

STAPHYLOCOCCUS AUREUS;

BLOTTING, WESTERN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENTEROTOXINS; EXOTOXINS; HUMANS; POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

EID: 84934442838     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-664-1_10     Document Type: Article

References (27)

1. (1999) From the Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. JAMA 282:1123-1125
2. Bergdoll MS, Crass BA, Reiser RF et al (1981) A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet 1: 1017-1021
3. Bernstein JM, Ballow M, Schlievert PM et al (2003) A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis. Am J Rhinol 17:321-326
4. Blomster-Hautamaa DA, Schlievert PM (1988) Preparation of toxic shock syndrome toxin-1. Methods Enzymol 165:37-43
5. Kravitz G, Dries DJ, Peterson ML et al (2005) Purpura fulminans due to Staphylococcus aureus . Clin Infect Dis 40:941-947
6. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339:520-532
7. McCormick JK, Yarwood JM, Schlievert PM (2001) Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 55:77-104
8. Dinges MM, Orwin PM, Schlievert PM (2000) Exotoxins of Staphylococcus aureus . Clin Microbiol Rev 13:16-34
9. Schlievert PM (1986) Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are signifi cantly associated with non-menstrual TSS. Lancet 1(1149):1150
10. Schlievert PM, Shands KN, Dan BB et al (1981) Identifi cation and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis 143:509-516
11. Schlievert PM, Tripp TJ, Peterson ML (2004) Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period. J Clin Microbiol 42:2875-2886
12. Lina G, Bohach GA, Nair SP et al (2004) Standard nomenclature for the superantigens expressed by Staphylococcus . J Infect Dis 189:2334-2336
13. Jarraud S, Cozon G, Vandenesch F et al (1999) Involvement of enterotoxins G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever. J Clin Microbiol 37: 2446-2449
14. Fey PD, Said-Salim B, Rupp ME et al (2003) Comparative molecular analysis of communityor hospital-acquired methicillin-resistant Staphylococcus aureus . Antimicrob Agents Chemother 47:196-203
15. Davis JP, Chesney PJ, Wand PJ et al (1980) Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 303:1429-1435
16. Shands KN, Schmid GP, Dan BB et al (1980) Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med 303:1436-1442
17. Todd JK, Kapral FA, Fishaut M et al (1978) Toxic shock syndrome associated with phage group 1 staphylococci. Lancet 2:1116-1118
18. Parsonnet J (1998) Case defi nition of staphylococcal TSS: a proposed revision incorporating laboratory fi ndings. Int Congr Symp Ser 229:15
19. Reingold AL, Hargrett NT, Dan BB et al (1982) Nonmenstrual toxic shock syndrome: a review of 130 cases. Ann Intern Med 96: 871-874
20. MacDonald KL, Osterholm MT, Hedberg CW et al (1987) Toxic shock syndrome: a newly recognized complication of infl uenza and infl uenza like illness. JAMA 257:1053-1058
21. Cone LA, Woodard DR, Byrd RG et al (1992) A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS. J Infect Dis 165:638-643
22. Hofer MF, Harbeck RJ, Schlievert PM et al (1999) Staphylococcal toxins augment specifi c IgE responses by atopic patients exposed to allergen. J Invest Dermatol 112:171-176
23. Hofer MF, Lester MR, Schlievert PM et al (1995) Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis. Clin Exp Allergy 25:1218-1227
24. Jackow CM, Cather JC, Hearne V et al (1997) Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus , and oligoclonal T-cell receptor V beta gene expansion [published erratum appears in Blood 1997 89:3496]. Blood 89: 32-40
25. Leung DY, Meissner HC, Fulton DR et al (1993) Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 342:1385-1388
26. Bohach GA, Fast DJ, Nelson RD et al (1990) Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 17:251-272
27. Marrack P, Kappler J (1990) The staphylococcal enterotoxins and their relatives. Science 248:705-711